Skip to content

MDR - Longevity IT Oblique and Offset Liners

PMCF Study to Provide Safety, Performance, and Clinical Benefits Data of the Longevity IT Oblique and Offset Liners in Primary and Revision Total Hip Arthroplasty - A Retrospective Enrollment/Prospective Follow-up Consecutive Series Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05980234
Enrollment
6
Registered
2023-08-07
Start date
2023-08-30
Completion date
2024-11-07
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Diastrophic Variant, Fracture of the Pelvis, Fused Hip, Non-inflammatory Degenerative Joint Disease (NIDJD), Osteoarthritis, Protrusio Acetabuli, Slipped Capital Femoral Epiphyses, Traumatic Arthritis

Brief summary

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumentation) at a minimum of 10-year follow-up.

Detailed description

The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary and revision total hip arthroplasty (implants and instrumentation) at 1, 3, 5, 7, and 10 years\*. The subject devices have been on the market since 2010 but have insufficient data to support 10 years of clinical history. A prospective aspect to the study will be utilized to collect long-term data.

Interventions

DEVICETotal Hip Arthroplasty with Longevity IT Offset Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Offset liners according to the approved indications and compatible device.

DEVICETotal Hip Arthroplasty with Longevity IT Oblique Liners

Primary or Revision Total Hip Arthroplasty using the Longevity IT Oblique liners according to the approved indications and compatible device.

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Study devices must have been implanted following the appropriate surgical technique and IFU * Patient must be 18 years of age or older * Patient must be willing and able to sign or verbally consent using the IRB approved informed consent * Patient must have undergone primary or revision hip arthroplasty with the Longevity IT Oblique and/or Offset liners according to a cleared indication, which includes the following: * Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis, protrusio acetabuli, traumatic arthritis, slipped capital, epiphysis, fused hip, fracture of the pelvis, and diastrophic variant * Revision where other devices or treatments have failed * Patient must have reached full skeletal maturity

Exclusion criteria

* Off-label use of study devices * Osteoradionecrosis * Neuromuscular compromise, vascular deficiency or other conditions in the affected limb that may lead to inadequate skeletal fixation * Systemic or local infection * Uncooperative patient or patient with neurologic disorders who is incapable of following directions * Patient is known to be pregnant or nursing * Patient is a prisoner * Patient is a known alcohol or drug abuser * Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of treatment-emergent Adverse Events (safety)10 yearsThis will be assessed by recording the incidence and frequency of revisions, complications, and adverse events with particular focus on those that may be related to the study device.

Secondary

MeasureTime frameDescription
Pain and Functional Performance - Oxford Hip Score10 yearsThe Oxford Hip Score is patient-reported outcome instrument which contains 12 questions on activities of daily living that assess function and residual pain in patients undergoing total hip replacement surgery. Grading the Oxford Hip Score 0 to 19-May indicate severe hip arthritis... 20 to 29-May indicate moderate to severe hip arthritis... 30 to 39-May indicate mild to moderate hip arthritis... 40 to 48-May indicate satisfactory joint function... Oxford Hip Score. (n.d.) Segen's Medical Dictionary. (2011). Retrieved August 19 2022 from https://medical-dictionary.thefreedictionary.com/Oxford+Hip+Score
Performance and Clinical Benefits - Harris Hip Score10 yearsPatient Assessment: reported Harris Hip Score (if available) Harris Hip Score: The HHS is divided into three sections. The first section questions is about pain and its impact, which are answered by the patient or client. The second and third sections require the physiotherapist to assess the patient or client's hip joint and function. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: \<70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.
Performance and Clinical Benefits - Activity Level10 yearsPatient Assessment: activity level Records patient's activity level on a 10-point scale from 'wholly inactive' to 'regularly particpates in impact sports.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026